GB0708445D0 - Compounds and uses thereof - Google Patents

Compounds and uses thereof

Info

Publication number
GB0708445D0
GB0708445D0 GBGB0708445.2A GB0708445A GB0708445D0 GB 0708445 D0 GB0708445 D0 GB 0708445D0 GB 0708445 A GB0708445 A GB 0708445A GB 0708445 D0 GB0708445 D0 GB 0708445D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0708445.2A
Other versions
GB2448895A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Activotec SPP Ltd
Original Assignee
Activotec SPP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activotec SPP Ltd filed Critical Activotec SPP Ltd
Priority to GB0708445A priority Critical patent/GB2448895A/en
Publication of GB0708445D0 publication Critical patent/GB0708445D0/en
Priority to PCT/GB2008/001489 priority patent/WO2008132477A1/en
Publication of GB2448895A publication Critical patent/GB2448895A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
GB0708445A 2007-05-01 2007-05-01 GLP-1 like compounds and uses thereof Withdrawn GB2448895A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0708445A GB2448895A (en) 2007-05-01 2007-05-01 GLP-1 like compounds and uses thereof
PCT/GB2008/001489 WO2008132477A1 (en) 2007-05-01 2008-04-29 Compounds and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0708445A GB2448895A (en) 2007-05-01 2007-05-01 GLP-1 like compounds and uses thereof

Publications (2)

Publication Number Publication Date
GB0708445D0 true GB0708445D0 (en) 2007-06-06
GB2448895A GB2448895A (en) 2008-11-05

Family

ID=38171030

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0708445A Withdrawn GB2448895A (en) 2007-05-01 2007-05-01 GLP-1 like compounds and uses thereof

Country Status (2)

Country Link
GB (1) GB2448895A (en)
WO (1) WO2008132477A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103333940B (en) * 2013-07-10 2015-04-15 浙江大学宁波理工学院 Method for preparing dipeptidyl peptidase IV (DPP-IV) inhibitory peptide through using hairtail
CN111378028A (en) * 2018-12-30 2020-07-07 万新医药科技(苏州)有限公司 Synthesis of acylated GLP-1 compounds and modified groups thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705483A (en) * 1993-12-09 1998-01-06 Eli Lilly And Company Glucagon-like insulinotropic peptides, compositions and methods
FR2777283B1 (en) * 1998-04-10 2000-11-24 Adir NOVEL GLUCAGON-PEPTIDE- 1 (7-37) ANALOGUE PEPTIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HU229208B1 (en) * 2000-06-16 2013-09-30 Lilly Co Eli Glucagon-like peptide-1 analogs
EP1539210A4 (en) * 2002-09-06 2006-06-07 Bayer Pharmaceuticals Corp Modified glp-1 receptor agonists and their pharmacological methods of use
US20060217300A1 (en) * 2003-02-19 2006-09-28 Biomeasure, Incorporated Analogues of glp-1
CA2550050A1 (en) * 2003-12-18 2005-06-30 Novo Nordisk A/S Novel glp-1 analogues linked to albumin-like agents
US7442682B2 (en) * 2004-10-19 2008-10-28 Nitto Denko Corporation Transepithelial delivery of peptides with incretin hormone activities
KR101011081B1 (en) * 2005-05-13 2011-01-25 일라이 릴리 앤드 캄파니 Glp-1 pegylated compounds
EP1922336B1 (en) * 2005-08-11 2012-11-21 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
EP1948676A4 (en) * 2005-10-27 2011-05-25 Peptron Co Ltd Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same
WO2007124461A2 (en) * 2006-04-20 2007-11-01 Amgen Inc. Glp-1 compounds

Also Published As

Publication number Publication date
GB2448895A (en) 2008-11-05
WO2008132477A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
HRP20180718T1 (en) Oligopeptidic compounds and uses thereof
IL244442B (en) Substituted acylanilide compounds and uses thereof
EP2114900A4 (en) Thiopyrimidine-based compounds and uses thereof
IL254218A0 (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
GB0701426D0 (en) Compounds and their use
HK1168843A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
GB0621160D0 (en) Compounds and uses thereof
EP2124908A4 (en) Compounds and uses thereof
EP2120563A4 (en) Compounds and uses thereof
EP2170874A4 (en) Novel compounds and their use
GB0718718D0 (en) Compound and use thereof
TWI367094B (en) 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands
GB0708445D0 (en) Compounds and uses thereof
EP2099459A4 (en) Compounds and uses thereof
EP2120957A4 (en) Compounds and uses thereof
IL200459A0 (en) Alpha-halo-and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
GB0711398D0 (en) Substituted organpolysiloxanes and uses thereof
GB0615557D0 (en) Compounds and Uses Thereof
GB0614091D0 (en) Compounds and their uses
GB0609834D0 (en) Compounds and their uses
GB0718562D0 (en) Compounds and their use
GB0718561D0 (en) Compounds and their use
GB0718560D0 (en) Compounds and their use
GB0702417D0 (en) Compounds and their use
GB0701795D0 (en) Compounds and their use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)